| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/12/2001 | WO2000072799A3 Method and compositions for treating the inflammatory response |
| 07/12/2001 | WO2000066097A3 Use of nicorandil in treatment of sexual dysfunctions or for enhancement of sexual functions |
| 07/12/2001 | WO2000064921A3 Process of purifying phytosterols from wood or plant-derived sources by means of metal salt complexes and compositions resulting therefrom |
| 07/12/2001 | WO2000063361A3 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 07/12/2001 | WO2000061230A3 Estrogen receptors-beta antagonism and bone diseases |
| 07/12/2001 | WO2000059490A8 Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
| 07/12/2001 | WO2000051589A3 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF |
| 07/12/2001 | WO2000041726A9 Noninvasive vascular therapy |
| 07/12/2001 | WO2000041528A9 Improved controlled release compositions and method |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000032205A9 Immunomodulatory methods using carbohydrate antigens |
| 07/12/2001 | WO2000005223A3 Heterocyclic derivatives and their use as integrin inhibitors |
| 07/12/2001 | US20010007907 3-epi vitamine D3 compounds having the orientation of the substituent attached to the carbon atom at 3-position of A-ring of vitamin D3 inverted from beta to alpha position;treats skin disorders such as hyperproliferation |
| 07/12/2001 | US20010007902 An oligonucleotide complementary to a region of the ribonucleotide component of telomerase attached to an activator of ribonuclease L (activator-antisense complex) which cleaves ribonuclotide portion of telomerase enzyme |
| 07/12/2001 | US20010007878 Mixture with a caloric density of about 2 calories/millileter of protein, fat, carbohydrates, vitamins and minerals, and arginine, which is essential to enhance the glomerular function of the kidneys |
| 07/12/2001 | US20010007875 Antidiabetic agents |
| 07/12/2001 | US20010007873 Compounds such as 4-(6-amino-pyridin-2-yl)-3-methoxyphenol as nitric oxide synthase inhibitors used to treat central nervous system disorders, inflammatory disorders, septic shock, etc... |
| 07/12/2001 | US20010007872 Administering a selective N-methyl-d-aspartate receptor antagonist |
| 07/12/2001 | US20010007871 Administering antioxidants, adensosine agonists, trophic factors, N-methyl-aspartic acid antagonists and steroids |
| 07/12/2001 | US20010007870 Compounds useful for inhibition of farnesyl protein transferase |
| 07/12/2001 | US20010007869 Alpha-substittuted pyridazino quinoline compounds |
| 07/12/2001 | US20010007868 Administering chelate compounds |
| 07/12/2001 | US20010007866 Treatment of pruritus with vitamin d and analogs thereof |
| 07/12/2001 | US20010007865 Prodrugs with enhanced penetration into cells |
| 07/12/2001 | US20010007863 Drugs; metabolism diseases; osteoporosis |
| 07/12/2001 | US20010007862 Aqueous solution of cyclodextrin |
| 07/12/2001 | US20010007856 Method for preventing and treating at a superacute phase, against neurological deficits or neuronal death in brain ischemia and pathological conditions |
| 07/12/2001 | US20010007771 Cationic polymers and lipids for the delivery of nucleic acids |
| 07/12/2001 | US20010007767 Genetic engineering |
| 07/12/2001 | US20010007764 Oligopeptides |
| 07/12/2001 | US20010007762 Process for macromolecularizing phenolic compounds etc. and use thereof |
| 07/12/2001 | US20010007761 Novel process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof |
| 07/12/2001 | US20010007754 Isolation an antimicrobial agent; complexing with genetic engineered b-lactamase inhibitor; detection; calibration |
| 07/12/2001 | US20010007749 Cancer screening |
| 07/12/2001 | US20010007693 Food products having enhanced cocoa polyphenol content and processes for producing the same |
| 07/12/2001 | US20010007681 Diltiazem controlled release formulation and method of manufacture |
| 07/12/2001 | US20010007680 Use of a film coating as taste-masking coating of oral dosage forms |
| 07/12/2001 | US20010007679 Administering (s,r)-formoterol, or a pharmaceutically acceptable salt thereof, said (s,r)-formoterol for inducing bronchodialation, relieving or preventing brohchospasm |
| 07/12/2001 | US20010007678 Melt extrusion mixture containing itraconazole |
| 07/12/2001 | US20010007674 Stimulate hair growth |
| 07/12/2001 | US20010007670 Novel formulations comprising lipid-regulating agents |
| 07/12/2001 | US20010007669 Antilipemic agent |
| 07/12/2001 | US20010007666 Destroying endosomal membrane in response to low pH |
| 07/12/2001 | US20010007665 Respiratory system |
| 07/12/2001 | US20010007651 Masking and eliminating odors; preservative, counterirritant, solubility enhancer, antiseptic, fungicide, microbiocide, anti-infective, healing agent; smoker's-breath; placebo |
| 07/12/2001 | DE19963868A1 Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New substituted piperidines, pharmaceutical compositions containing them and methods for their preparation |
| 07/12/2001 | DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 07/12/2001 | DE19963175A1 Verwendung von substituierten 4-Amino-1-phenylbutan-2-ol-Verbindungen als Arzneimittel Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/12/2001 | DE19963174A1 Substituierte Pyrrol-Mannichbasen Substituted pyrrole Mannich bases |
| 07/12/2001 | DE19962828A1 Screeningsverfahren für Chemotherapeutika Screening method for chemotherapeutic agents |
| 07/12/2001 | DE19962470A1 Verwendung von Chemotherapeutika Use of chemotherapeutic agents |
| 07/12/2001 | DE19960154A1 Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie Flat pharmaceutical preparation for transmucosal administration of oxycodone or a similar drug in the oral cavity, for use in the treatment of pain and addiction treatment |
| 07/12/2001 | DE19957341A1 Synergistic compositions containing thalidomide compound and phosphodiesterase IV inhibitor useful for treatment of inflammation, autoimmune diseases, chronic infection and tumors |
| 07/12/2001 | DE19957287A1 Treatment of symptoms associated with loosening of implanted endoprostheses, e.g. pain, by administration of a homeopathic preparation of zinc or a zinc compound, e.g. zinc gluconate |
| 07/12/2001 | DE19945351A1 Verfahren zum Auffinden und zur Isolierung pharmakologisch wirksamer Verbindungen aus Substanzgemischen sowie eine Vorrichtung zur Durchführung des Verfahrens A method for finding and isolating pharmacologically active compounds from substance mixtures, and an apparatus for carrying out the method |
| 07/12/2001 | DE10061801A1 New compositions containing hydrophilic film former, water and urea useful for non-traumatic removal of fungally infected areas in finger- and toenails |
| 07/12/2001 | DE10000739A1 New piperidine and piperazine derivatives which are antagonists of certain serotonin receptors, are useful in treatment of, e.g. eating disorders, stroke, anxiety or Parkinson's disease |
| 07/12/2001 | DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives |
| 07/12/2001 | CA2733819A1 Iron chelator delivery system |
| 07/12/2001 | CA2475413A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2475393A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2396688A1 Glycosidase inhibitors and methods of synthesizing same |
| 07/12/2001 | CA2396595A1 Non-peptide inhibition of t-lymphocyte activation and therapies related thereto |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396393A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | CA2396379A1 Pharmaceutical compositions for oral administration |
| 07/12/2001 | CA2396315A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them |
| 07/12/2001 | CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396306A1 Method for preparing hydroxypicolinic acid derivatives |
| 07/12/2001 | CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | CA2396299A1 Picolinic acid derivatives and their use as fungicides |
| 07/12/2001 | CA2396276A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | CA2396257A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | CA2396240A1 Methods for inhibiting/treating hiv infections and aids related symptoms |
| 07/12/2001 | CA2396234A1 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 07/12/2001 | CA2396178A1 Novel therapeutic use of enoxaparin |
| 07/12/2001 | CA2396068A1 Antisense antibacterial cell division composition and method |
| 07/12/2001 | CA2396059A1 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | CA2395984A1 Novel heteroaryl derivatives, their preparation and use |
| 07/12/2001 | CA2395976A1 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl |
| 07/12/2001 | CA2395966A1 Multi-tablet oxybutynin system for treating incontinence |
| 07/12/2001 | CA2395955A1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395867A1 Phenylpiperazinyl derivatives |
| 07/12/2001 | CA2395795A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 07/12/2001 | CA2395742A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | CA2395695A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/12/2001 | CA2395660A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | CA2395642A1 Use of steroidal alkaloids to reverse multidrug resistance |
| 07/12/2001 | CA2395636A1 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | CA2395606A1 Novel indole derivatives |
| 07/12/2001 | CA2395132A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | CA2394721A1 Product for treating gynecomastia |
| 07/12/2001 | CA2394597A1 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/12/2001 | CA2394297A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | CA2394199A1 5,10-dihydroacridines as calcium channel blockers |
| 07/12/2001 | CA2394184A1 Methods and compositions for mitigating pain using nitrate esters |
| 07/12/2001 | CA2362453A1 Treatment of acne using lipoic acid |